Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
So far, studies have reported: Phase 2 (48 weeks): up to 24.2% average weight loss Phase 3 TRIUMPH-4 topline (68 weeks): 28.7% average weight loss (press release) What that looks like: If you start at 100 kg : 24.2% 24 kg average loss 28.7% 29 kg average loss Side effects and safety signals (what we know so far) Phase 2 (peer-reviewed) In the phase 2 trial, the most common adverse events were gastrointestinal and dose-related, typically mild to moderate
Peptides offered for sale are intended strictly for laboratory research purposes
Androgenetic alopecia unmasking Rapid weight loss and hormonal shifts can unmask or accelerate androgenetic alopecia (pattern hair loss) in genetically susceptible individuals
J Hepatol 2024;80:419-430
PMC+1 Further, their original authorisation and indication were for glucose-controlnot for long-term, standalone obesity treatment
US$ 23.07
US$ 24.13
US$ 21.58
US$ 28.74
US$ 28.30
US$ 25.69
US$ 27.72
US$ 22.59
